Cas No.: 945245-76-1
PRODUCT INFORMATION
Description
LSD is a peptide-based agent demonstrating selective targeting specificity toward melanoma-derived lymphatic endothelial cells (LECs) in C8161 models, without cross-reactivity to normal tissue lymphatics. Conjugation with pro-apoptotic peptides has been used to study the reduction of tumor lymphatic density in vivo. This peptide serves as a specialized tool for investigating lymphatic-specific molecular interactions and pathways in oncological research models.
Molecular Weight
1009.20
Purity
> 95%
Formula
C₃₉H₇₂N₁₄O₁₃S₂
Product Type
Targeting Peptide
Sequence
Cys-Leu-Ser-Asp-Gly-Lys-Arg-Lys-Cys
Form (20 deg.C)
Solid
Storage Condition
Store sealed at -20°C, away from moisture.
For Research Use Only | Not For Clinical Use
Related products
- NBD-LLLLpY Targeting Peptide (CAT#: OLY-1025-YS-50)
- C16Y Targeting Peptide (CAT#: OLY-1025-YS-7)
- P160 Targeting Peptide (CAT#: OLY-1025-YS-21)
- CooP Targeting Peptide (CAT#: OLY-1025-YS-12)
- Octreotide Pamoate Targeting Peptide (CAT#: OLY-1025-YS-4)
- Thrombin-cleavable Targeting Peptide (CAT#: OLY-1025-YS-34)
- Cys-PKHB1 Targeting Peptide (CAT#: OLY-1025-YS-33)
- Osteocalcin (1-49) (human) Targeting Peptide (CAT#: OLY-1025-YS-9)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.